Rodolfo Savitzky appointed as new CFO for Lonza Group to succeed Toralf Haag who was appointed as CFO of the Voith Group in Germany
(PresseBox) (Basel, )Rodolfo Savitzky (54) joined Lonza in March 2015 as Head of Finance & Controlling for the Pharma&Biotech segment. Previously he was Chief Financial Officer for the Animal Health Division of Novartis. Prior to this position, Rodolfo Savitzky held various financial management positions with increasing responsibilities at Novartis and Procter & Gamble. He holds an MBA in Finance/Economics from the University of Chicago. With his broad financial and industry background, his thorough understanding of Lonza’s strategic direction and his contributions to the Pharma&Biotech segment, Rodolfo Savitzky brings the necessary skillset to his new position.
Toralf Haag joined Lonza in 2005 as CFO and since then successfully led the financial organization of Lonza. He was significantly involved in the strategic development of Lonza and managed M&A projects successfully, as well as refinancing projects and the deleveraging of the company.
“I would like to take this opportunity to express my sincere thanks to Toralf for the services he has provided to this company. He led the finance department vigilantly and managed to steer the financial activities of Lonza successfully also through difficult times. Today he can hand over a financially solid company with a healthy balance sheet,” said Lonza CEO Richard Ridinger. “With Rodolfo Savitzky we found an excellent internal solution; and with the handover in early October, we can benefit from a well-planned and thought-through handover process, in which Toralf will continue to support a number of important projects.”
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.